Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2007
09/13/2007US20070213601 Method and apparatus for penetrating tissue
09/13/2007US20070213523 adding three or more sugars with high reproducibility, disulfide bond immobilized on protein-analyzing sensor chip; oligoethylene oxide group enables linker cmpd to minimize nonspecific hydrophobic interaction; metal-sulfur bond; 1,2-dithiolane on tri-branched amino acid attached to oligosaccharide; SPR
09/13/2007US20070213391 Furosemide modulators of hm74
09/13/2007US20070213307 Methods to treat autoimmune and inflammatory conditions
09/13/2007US20070213278 Arrays with cleavable linkers
09/13/2007US20070213268 inhibiting angiogenesis in tissues expressing a endocrine gland-derived vascular endothelial growth factor(EG-VEGF) polypeptide, comprising contacting the tissue with an antagonist antibody of the EG-VEGF polypeptide or an antigen binding fragment; regulating cellular proliferation and chemotaxis
09/13/2007US20070213266 Methods for using and identifying modulators of Delta-like 4
09/13/2007US20070213256 Novel genes and proteins encoded thereby
09/13/2007US20070213255 Novel Hyaluronan-Binding Proteins and Encoding Genes
09/13/2007US20070212794 Magnetic immunoassay system
09/13/2007US20070212790 Method for monitoring feeds to catalytic cracking units by near-infrared spectroscopy
09/13/2007US20070212789 Using metal porphyrin luminescent compound and emitted light as tools in determining concentration of oxygen in closed packages containing meat products
09/13/2007US20070212788 Methods for detecting modulators of cytokine receptor zalpha11
09/13/2007US20070212787 Method of quantitatively measuring trace amounts of metals in polymer samples
09/13/2007US20070212786 Monitoring heparin by microelectronic devices
09/13/2007US20070212761 Incubating sample with probe having secondary structure that changes upon binding; nuclease cleavage; releasing signal generating fragment
09/13/2007US20070212756 Methods for treating lentivirus infections
09/13/2007US20070212744 Device For Analyzing The Coagulation Or Aggregation Behavior Of Blood
09/13/2007US20070212743 Assays for Determining Anticoagulant Cofactor Activity
09/13/2007US20070212742 Determination of a Midregional Proadrenomedullin Partial Peptide in Biological Fluids for Diagnostic Purposes, and Immunoassays for Carrying out Such a Determination
09/13/2007US20070212741 Diagnostic markers for sub-acute ruminal acidosis
09/13/2007US20070212740 distinguishing between mammals presenting an active form of tuberculosis and mammals not infected by M. tuberculosis or presenting a latent form of tuberculosis; heparin binding haemagglutin (HBHA); PBMC ( peripheral blood mononuclear cells)
09/13/2007US20070212739 Novel cancer-associated antigens and methods of their identification and use
09/13/2007US20070212738 Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
09/13/2007US20070212737 Using CD44 expression profile as diagnostic indicator of cell proliferative disorders
09/13/2007US20070212736 Functional Immunohistochemical Cell Cycle Analysis as a Prognostic Indicator for Cancer
09/13/2007US20070212735 Using maytansinoid conjugated monoclonal antibody to treat cell proliferative disorders
09/13/2007US20070212734 Method for Distinguishing T(11Q23)/Mll-Positive Leukemias From t(11Q23)/Mll Negative Leukemia
09/13/2007US20070212733 Methods and compositions related to B cell assays
09/13/2007US20070212732 Enriched Pancreatic Stem Cell and Progenitor Cell Populations, and Methods for Identifying, Isolating and Enriching for Such Populations
09/13/2007US20070212731 Sample is mixed with a solid support having ligand immobilized; irradiating light in the presence of 2-mercaptoethanol and/or hydrazine, and confirming binding of the target molecule to the ligand; protein purification; for analyzing the interaction between a ligand and a target molecule
09/13/2007US20070212730 Covalently immobilized protein gradients in three-dimensional porous scaffolds
09/13/2007US20070212729 Prognostic Methods for Congestive Heart Failure
09/13/2007US20070212728 32263, a novel human biotin enzyme and uses thereof
09/13/2007US20070212726 Incubating sample with probe having secondary structure that changes upon binding; nuclease cleavage; releasing signal generating fragment
09/13/2007US20070212725 Incubating sample with probe having secondary structure that changes upon binding; nuclease cleavage; releasing signal generating fragment
09/13/2007US20070212724 Methods of detecting a target nucleic acid
09/13/2007US20070212722 generating a signal indicative of the presence of a target nucleic acid in a sample by forming a cleavage structure through incubating a sample with a probe containing a binding moiety and having a secondary structure that changes upon binding and cleaving the cleavage structure with a nuclease
09/13/2007US20070212721 Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor
09/13/2007US20070212717 Method for Inhibiting Hepatitis C Virus Replication
09/13/2007US20070212716 Nezara viridula Ecdysone Receptor
09/13/2007US20070212709 Non-nucleosidic linker linking xanthene donor to 4,7-dichlororhodamine acceptor;
09/13/2007US20070212701 Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof
09/13/2007US20070212699 Process for high throughput DNA methylation analysis
09/13/2007US20070212693 Factor reca from bacillus licheniformis and reca-inactivated safety stems used for biotechnological production
09/13/2007US20070212691 Cytolethal Distending Toxins and Detection of Campylobacter Bacteria Using the Same as a Target
09/13/2007US20070212690 Folate Antagonists Having Improved Selectivity
09/13/2007US20070212688 Method For Distinguishing Cbf-Positive Aml Subtypes From Cbf-Negative Aml Subtypes
09/13/2007US20070212687 Method For Distinguishing Mll-Ptd-Positive Aml From Other Aml Subtypes
09/13/2007US20070212686 Use Of T-Cadherin As A Target
09/13/2007US20070212685 Utilizing SCN9A (sodium channel alpha subunits) gene and expression products thereof for the screening and identification of therapeutic agents; in vitro method for identifying a selective inhibitor of human SCN9A
09/13/2007US20070212682 Methods And Apparatus For Detection Of Viral Infection
09/13/2007US20070212679 Assay for parkinson's disease therapeutics and enzymatically active parkin preparations useful therein
09/13/2007US20070212678 Method And Apparatus For Predicting Aggregation Kinetics Of A Biologically Active Material
09/13/2007US20070212677 Identifying off-target effects and hidden phenotypes of drugs in human cells
09/13/2007US20070212555 Preparation of Nanometric Arrays of Biomolecules on Oligo-or Poly(Ethylene Glycol) Films on Silicon Surfaces
09/13/2007US20070212423 Stem cells that transform to beating cardiomyocytes
09/13/2007US20070212378 Methods And Compositions For Mycoplasma Pneumoniae Exotoxins
09/13/2007US20070212370 Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
09/13/2007US20070212369 Colon Specific Genes and Proteins
09/13/2007US20070212368 Proteins
09/13/2007US20070212366 Use Of Mrp4-Inhibitors For The Treatment And/Or Prophylaxis Of Cardiovascular Diseases
09/13/2007US20070212365 recombinantly produced polypeptide; contacting a vascular cell with polypeptide for inhibiting angiogeneisis
09/13/2007US20070212359 Cancer Diagnosis And Treatment Of Cancer Using Anti-Robo 1 Antibody
09/13/2007US20070212353 Novel therapeutic target and diagnostic marker for asthma and related conditions
09/13/2007US20070212351 Novel therapeutic targets in cancer
09/13/2007US20070212348 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation
09/13/2007US20070212347 Compositions and methods for treating polycystic kidney disease gene
09/13/2007US20070212345 Methods And Compositions For The Prevention And Treatment Of Gentiourinary Disorders Including Pre-Term Labor And Leiomyomas
09/13/2007US20070212344 Pharmaceutical preparation with RNA as hemostasis cofactor
09/13/2007US20070212299 A gene (designated 161P2F10B) and its encoded protein which exhibits tissue specific expression in normal adult tissue and is aberrantly expressed in the cancers; medical diagnostis;, prognosis, prophylactis and/or gene therapy; tissue-target therapy; used to elicit a humoral or cellular immune response
09/13/2007US20070212263 Micro Thermoelectric Type Gas Sensor
09/13/2007US20070212262 Fluidic system for a flow cytometer
09/13/2007US20070210262 Non-contact oil spill detection apparatus and method
09/13/2007US20070209995 Extracting apparatus
09/13/2007US20070209950 Methods and devices for the detection and measurement of free metals in fluids and methods for diagnosing metal-related diseases and for determining pharmacologic dosing regimens
09/13/2007US20070209935 Multiaperture Sample Positioning and Analysis System
09/13/2007US20070209455 Dosage form holder device and methods for immersion testing
09/13/2007US20070209423 Material stream sensors
09/13/2007DE202007007172U1 Stuhlfänger HT zur einfachen Entnahme von Stuhlproben bei Tiefspültoiletten Chair HT catcher for easy removal of faeces in Tiefspültoiletten
09/13/2007DE202007006983U1 Vorrichtung mit Doppellanze zur Feld-Bodenanalytik Device with double lance for field soil analysis
09/13/2007DE202007003784U1 Vorrichtung zur Reinigung von Biomolekülen Apparatus for the purification of biomolecules
09/13/2007DE202007003507U1 Anordnung zum Testen der Zerfallszeit und der Wirkstofffreigabe von Prüflingen in Flüssigkeiten Arrangement for testing the disintegration time and the drug release of samples in liquids
09/13/2007DE102006011345A1 Active electric potentials measurement and cell membranes permeabilization device for use in e.g. biotechnology, has cells that are electroporated in tissue medium by high voltage impulse to maintain state over integrity of membranes
09/13/2007DE102006010959A1 Vorrichtung zum Nachweis biochemischer Zielmoleküle und Verfahren zur Herstellung der Vorrichtung An apparatus for detecting biochemical target molecules and methods of making the device
09/13/2007DE102006010958A1 Verfahren zur Durchführung einer Reaktion zur Vervielfältigung einer Nukleinsäure A method of performing a reaction for the amplification of a nucleic acid
09/13/2007DE102006010647A1 Test zum Nachweis von pathologischen Prionen Test for the detection of pathological prion
09/13/2007DE102006010495A1 Verfahren und Substrat zur Immobilisierung von Biomolekülen A method and substrate for immobilizing biomolecules
09/13/2007DE102006005476A1 Vorrichtung zum Bestimmen einer Kenngröße einer Metallschmelze oder einer auf der Metallschmelze aufliegenden Schlackeschicht An apparatus for determining a characteristic of a molten metal or a molten metal resting on the slag layer
09/13/2007DE102004027865B4 Leitende Kohlenstoff-Nanotubes, dotiert mit einem Metall, und Verfahren zur Herstellung eines Biosensors, der diese benutzt Conductive carbon nanotubes, doped with a metal, and method for producing a biosensor that uses this
09/13/2007CA2646987A1 Method and apparatus for target detection using electrode-bound viruses
09/13/2007CA2645310A1 Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
09/13/2007CA2645277A1 Compositions and methods based on peptide binding profiling
09/13/2007CA2645211A1 Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
09/13/2007CA2645134A1 Compositions and methods for detection and treatment of human herpesvirus (hhv)-6
09/13/2007CA2645125A1 Methods for diagnosing pancreatic cancer using reg4 protein
09/13/2007CA2644856A1 Human embryonic stem cell methods and podxl expression
09/13/2007CA2644588A1 Truncated proteins as cancer markers
09/13/2007CA2644548A1 Genetic packages and uses thereof
09/13/2007CA2644529A1 Anti-drug antibody assay